These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
584 related articles for article (PubMed ID: 33730376)
21. Use of the sustained pain-free plus no adverse events endpoint in clinical trials of triptans in acute migraine. Dodick DW; Sandrini G; Williams P CNS Drugs; 2007; 21(1):73-82. PubMed ID: 17190530 [TBL] [Abstract][Full Text] [Related]
22. Meta-analysis of the efficacy and safety of zolmitriptan in the acute treatment of migraine. Chen LC; Ashcroft DM Headache; 2008 Feb; 48(2):236-47. PubMed ID: 18179569 [TBL] [Abstract][Full Text] [Related]
23. Newer formulations of the triptans: advances in migraine management. Gladstone JP; Gawel M Drugs; 2003; 63(21):2285-305. PubMed ID: 14524731 [TBL] [Abstract][Full Text] [Related]
28. The use of multiattribute decision models in evaluating triptan treatment options in migraine. Ferrari MD; Goadsby PJ; Lipton RB; Dodick DW; Cutrer FM; McCrory D; Williams P J Neurol; 2005 Sep; 252(9):1026-32. PubMed ID: 15761676 [TBL] [Abstract][Full Text] [Related]
29. Multiple attack study on the available triptans in Italy versus placebo. Vollono C; Capuano A; Mei D; Ferraro D; Pierguidi L; Evangelista M; Di Trapani G Eur J Neurol; 2005 Jul; 12(7):557-63. PubMed ID: 15958097 [TBL] [Abstract][Full Text] [Related]
30. Theory-based analysis of clinical efficacy of triptans using receptor occupancy. Tokuoka K; Takayanagi R; Suzuki Y; Watanabe M; Kitagawa Y; Yamada Y J Headache Pain; 2014 Dec; 15(1):85. PubMed ID: 25488888 [TBL] [Abstract][Full Text] [Related]
31. Patient satisfaction with rizatriptan versus other triptans: direct head-to-head comparisons. Gerth WC; McCarroll KA; Santanello NC; Vandormael K; Zhang Q; Mannix LK Int J Clin Pract; 2001 Oct; 55(8):552-6. PubMed ID: 11695077 [TBL] [Abstract][Full Text] [Related]
32. [Economic evaluation of acute migraine attack treatment with triptans in Spain]. Gracia-Naya M; Rejas Gutiérrez J; Latorre Jiménez A; González Garcia P Neurologia; 2005 Apr; 20(3):121-32. PubMed ID: 15815947 [TBL] [Abstract][Full Text] [Related]
33. Network meta-analysis of migraine disorder treatment by NSAIDs and triptans. Xu H; Han W; Wang J; Li M J Headache Pain; 2016 Dec; 17(1):113. PubMed ID: 27957624 [TBL] [Abstract][Full Text] [Related]
34. Transfer of cetirizine/levocetirizine into human breast milk and estimation of drug exposure to infants through breastfeeding: A human lactation study from the ConcePTION project. Nordeng H; Wegler C; Lindqvist A; Melander E; Magnusson M; Gandia P; Panchaud A; Baranczewski P; Spigset O Basic Clin Pharmacol Toxicol; 2024 Jan; 134(1):153-164. PubMed ID: 37811726 [TBL] [Abstract][Full Text] [Related]
35. Rizatriptan: an update of its use in the management of migraine. Wellington K; Plosker GL Drugs; 2002; 62(10):1539-74. PubMed ID: 12093318 [TBL] [Abstract][Full Text] [Related]
36. Spotlight on rizatriptan in migraine. Wellington K; Jarvis B CNS Drugs; 2002; 16(10):715-20. PubMed ID: 12269863 [TBL] [Abstract][Full Text] [Related]
37. Pre-exposure Prophylaxis Use by Breastfeeding HIV-Uninfected Women: A Prospective Short-Term Study of Antiretroviral Excretion in Breast Milk and Infant Absorption. Mugwanya KK; Hendrix CW; Mugo NR; Marzinke M; Katabira ET; Ngure K; Semiyaga NB; John-Stewart G; Muwonge TR; Muthuri G; Stergachis A; Celum CL; Baeten JM PLoS Med; 2016 Sep; 13(9):e1002132. PubMed ID: 27676257 [TBL] [Abstract][Full Text] [Related]
38. Acute management of migraine: triptans and beyond. Diener HC; Limmroth V Curr Opin Neurol; 1999 Jun; 12(3):261-7. PubMed ID: 10499171 [TBL] [Abstract][Full Text] [Related]
39. Triptan use in Australia 1997-2015: A pharmacoepidemiological study. Eyre BLKD; Eadie MJ; van Driel ML; Ross-Lee L; Hollingworth SA Acta Neurol Scand; 2017 Aug; 136(2):155-159. PubMed ID: 28093722 [TBL] [Abstract][Full Text] [Related]